The Clinical Immunology Society (CIS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education to physicians. CIS current accreditation is valid until March 31, 2022.
CIS directly sponsors CME for its own programs and jointly providership CME for other related organization programs. The CME program is overseen by the CIS Executive Committee and CME Committee.
The CIS CME program operates in a health care environment where the patients that meeting participants treat, range across a broad spectrum of clinical immunology. Patients of the physician participants in the CME Program can be found in specific areas such as Allergy/Asthma, HIV, Primary Immune Deficiencies, Immunology of Diabetes/Endocrine Disorders, Autoimmune Disorders, Rheumatoid Arthritis, Multiple Sclerosis (and other Neuroimmunologic Disorders), Systemic Lupus Erythematosus, Mucosal Immunology related diseases, Transplantation (Organ/Bone Marrow), Inflammatory Eye Diseases, Rheumatology, Immunohematology and Tumor Immunology.
The leadership of CIS views CME as a strategic initiative and an important member benefit in this time of changing medical education. The CIS CME program uses practice-based needs to match the content of programs to the learner’s scope of practice, in addition to his or her future or potential scope of practice, to measure change in competence.